2015-07-17 23:09:41 UTC

Help Standardize How Endoscopic Image Evaluations are Processed

July 21, 2015

The early registration and hotel reservation deadline is Sept. 3, 2015 for the conference.

We hope to see you this fall Oct. 2, 2015, in Washington, DC, for the first conference developed by the new AGA Center for Diagnostics and Therapeutics.

The event, Endoscopic Disease Activity Evaluation in IBD: Factors Influencing Disease Activity Interpretation in Clinical Practice and Clinical Trials, brings together IBD experts and representatives from FDA to examine the process of reading of images in IBD clinical trials of medical therapy. 

 The early registration and hotel reservation deadline is Sept. 3, 2015.

By attending this conference, you will be able to:

  • Understand the appropriate steps necessary for validation of an endoscopic index for patients with UC or Crohn’s.
  • Recognize and review current endoscopic assessment instruments used for regulatory approval in Crohn's or UC
  • Review the benefits and limitations of current endoscopic assessment instruments used for regulatory approval in Crohn's or UC. 
  • Discuss appropriate endoscopic endpoints that might be used for regulatory approval in patients with Crohn's or UC. 
  • Review possible benefits and limitations of central and local reading of endoscopic images from patients with UC or Crohn's.

Do not miss the opportunity to be a part of this unique forum and help standardize and validate the process by which endoscopic images are evaluated. Register today at www.gastro.org/cdt15.

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Insurance Barriers Should Not Hinder Step Therapy Treatment for IBD

Dec. 13, 2017

AGA participated in a congressional briefing to highlight the need for physician use of step therapy treatment without barriers.